Status | Study |
Completed |
Study Name: Development of a Screening Tool to Detect and Stage Cachectic Cancer Patients Condition: Cachexia Date: 2012-02-10 |
Terminated |
Study Name: The Role of Ghrelin in Cancer Cachexia Condition: Cancer Cachexia Date: 2011-12-07 Interventions: Drug: Anamorelin HCl 100 mg ta |
Completed |
Study Name: A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study Condition: Cancer Cachexia Date: 2011-08-16 Interventions: Other: Multimodal intervention |
Completed |
Study Name: A Clinical Study With MT-102 in Subjects With Cancer Cachexia Condition: Cancer Cachexia Date: 2010-11-09 Interventions: Drug: MT-102 BETA BLOCKER |
Terminated |
Study Name: Lenalidomide for Lean Body Mass and Muscle Strength in Inflammatory Cancer Cachexia Syndrome Condition: Cancer Cachexia Syndrome Date: 2010-05-12 Interventions: Drug: Lenalidomide 25mg od, do |
Recruiting |
Study Name: Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II Study Condition: Advanced Cancer Cachexia Date: 2009-07-06 Interventions: Drug: ghrelin As starting dose the investigators choose a dose level which was shown in our last study t |
Completed |
Study Name: Pilot Study of APD209 in Cancer Cachexia Condition: Cancer-related Cachexia Date: 2009-05-07 Interventions: Drug: APD209 Oral tablets twice per day for 56 days |
Completed |
Study Name: A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia Condition: Cancer Cachexia Date: 2008-12-29 Interventions: Drug: Eicosapentaenoic Acid Participants will receive Lovaza at a dose of 4 g for 6 weeks. Participants |
Terminated |
Study Name: Protein-energy Oral Supplementation Enriched With Omega-3 Fatty Acids in Cardiac Cachexia Condition: Cardiac Cachexia Date: 2008-09-04 Interventions: Dietary Supplement: Fortimel Extra® |
Completed |
Study Name: SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD) Condition: Cachexia Date: 2008-05-01 Interventions: Drug: Placebo comparator Twice |